Qiang Xu - Profile and Investment Details

Investor Profile

Qiang Xu is a Venture Capital, Private Equity Firm based in Menlo Park, California, United States with a diverse investment portfolio that includes companies such as LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue, Hummingbird Bioscience, SentreHEART, GeneWEAVEBaoyuan Biomedical, Invitae, ReadCoor, Bioheng, IMPACT Therapeutics, BCFoods, AccuraGen Holdings, Genapsys, Terns Pharmaceuticals, Polares Medical, Mynosys Cellular Devices, Encodia, Omniome, Apexigen, Osel Inc., Everest Medicines, Checkmate Pharmaceuticals, Neurelis, Pan Pacific Pharmaceuticals, Inc., AnHeart Therapeutics, VelosBio, Mindstrong, Sema4, Aadi Bioscience, Equillium, Arcus Biosciences, EpimAb Biotherapeutics, KeChow Pharma, . Over time, Qiang Xu has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Qiang Xu is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Healthcare Innovation, Chemical, Life Science, Portfolio Management, Medical Technologies, Artificial Intelligence (AI), Analytics, Finance, Manufacturing, Biotechnology, Medical Devices, Clinical Trials, Early Stage IT, Health Diagnostics, Innovation Management, Medical, B2B, Therapeutics, Machine Learning, Pharmaceuticals, Healthcare Technology, Acquisitions may find it worthwhile to explore potential connections with Qiang Xu, as their portfolio suggests a familiarity and interest in this area.

Understanding Qiang Xu’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.